These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691 [TBL] [Abstract][Full Text] [Related]
27. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature. Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721 [TBL] [Abstract][Full Text] [Related]
28. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853 [TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations. Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194 [TBL] [Abstract][Full Text] [Related]
30. A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. Li Y; Simonds WF; Chen H J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39044678 [TBL] [Abstract][Full Text] [Related]
31. Genetics and Epigenetics of Parathyroid Carcinoma. Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432 [TBL] [Abstract][Full Text] [Related]
32. Parathyroid Cancer in the Pediatric Patient. Davidson JT; Lam CG; McGee RB; Bahrami A; Diaz-Thomas A J Pediatr Hematol Oncol; 2016 Jan; 38(1):32-7. PubMed ID: 26650250 [TBL] [Abstract][Full Text] [Related]
33. Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing. Su S; Zou JJ; Zeng YY; Cen WC; Zhou W; Liu Y; Su DH; Zhang XL; Huang HY; Lei A; Huang ZH; Jin Y; Li L; Su N; Xie YL; Zhao ZG; Liu JX Biomed Res Int; 2019; 2019():6096350. PubMed ID: 31781628 [TBL] [Abstract][Full Text] [Related]
34. The clinicopathological features of lung metastases of parathyroid cancinoma. Li Q; Shi Z; Zhou X; Xu M; Zhao T; Wei B; Zhang Y; Liu H; Tian Z; Zhang Y; Lu J Pathol Res Pract; 2024 Aug; 260():155449. PubMed ID: 38981345 [TBL] [Abstract][Full Text] [Related]
35. Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Adamson AW; Ding YC; Steele L; Leong LA; Morgan R; Wakabayashi MT; Han ES; Dellinger TH; Lin PS; Hakim AA; Wilczynski S; Warden CD; Tao S; Bedell V; Cristea MC; Neuhausen SL J Ovarian Res; 2023 Jul; 16(1):141. PubMed ID: 37460928 [TBL] [Abstract][Full Text] [Related]
36. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300 [TBL] [Abstract][Full Text] [Related]